Search results for “PARP inhibitor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,581 patents, we discovered top 194 key players by total patent application. Janssen Pharmaceutica NV, BiPar Sciences, Inc., BeiGene Ltd. are dominant in this area. They take 23.91% of the total patent filing.
Antwerpen, Belgium
Patent: 213
California, United States
Patent: 100
Massachusetts, United States
Patent: 65
Hessen, Germany
Patent: 55
New Jersey, United States
Patent: 53
Illinois, United States
Patent: 52
Jiangsu Sheng, China
Patent: 51
Maharashtra, India
Patent: 49
Illinois, United States
Patent: 46
New York, United States
Patent: 34
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 38 patents, we discovered top 11 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Ashvattha Therapeutics Inc, NiKang Therapeutics, Inc. are active in this area.
STARTUP
France
Patent: 11
STARTUP
California, United States
Patent: 6
STARTUP
Delaware, United States
Patent: 6
STARTUP
United States
Patent: 4
STARTUP
South Korea
Patent: 3
STARTUP
Eisbach Bio GmbH
Bayern, Germany
Patent: 2
STARTUP
California, United States
Patent: 2
STARTUP
Shanghai Shi, China
Patent: 1
STARTUP
Essex, United Kingdom
Patent: 1
STARTUP
South Korea
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 607 patents applied in the last 5 years. We discover 183 most active companies in this area. The fast-growing Jiangsu Hengrui Pharmaceuticals Co., Ltd., Pfizer Inc., Lupin Ltd take 16.47% of patent filing during this period.
Jiangsu Sheng, China
Patent: 48
New York, United States
Patent: 28
Maharashtra, India
Patent: 24
Antwerpen, Belgium
Patent: 23
Hessen, Germany
Patent: 22
Massachusetts, United States
Patent: 22
Massachusetts, United States
Patent: 20
New Jersey, United States
Patent: 20
Jiangsu Sheng, China
Patent: 18
The Board of Regents of The University of Texas System
Texas, United States
Patent: 16
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 607 patents in last 5 years, we discover 139 new entrants. Daiichi Sankyo Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Repare Therapeutics, Inc. are the most active new entrants in this area.
New Jersey, United States
Patent: 20
Jiangsu Sheng, China
Patent: 18
Quebec, Canada
Patent: 14
Colorado, United States
Patent: 11
Massachusetts, United States
Patent: 9
United States
Patent: 8
Alabama, United States
Patent: 7
Jiangsu Sheng, China
Patent: 6
STARTUP
Delaware, United States
Patent: 6
STARTUP
California, United States
Patent: 6
Research Institutions
Order by:
Innovation Intensity
With the analysis among 226 patents, we discovered top 57 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, King's College London, Université Paris-Saclay are dominant in this area. They take 20.80% of the total patent filing.
Shanghai Shi, China
Patent: 13
United Kingdom
Patent: 12
CENTRE COUNTY, France
Patent: 10
United States
Patent: 8
Massachusetts, United States
Patent: 8
Central Region, Singapore
Patent: 5
Jiangsu Sheng, China
Patent: 5
Quebec, Canada
Patent: 4
Central Region, Singapore
Patent: 4
United Kingdom
Patent: 4
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: